Podcast - Key Considerations for Reshoring U.S. Drug Manufacturing

You must have a iHealthFlix subscription and be logged in to watch videos

Login or Subscribe

On this Diagnosing Health Care episode, “Key Considerations for Reshoring U.S. Drug Manufacturing,” dive into the key business, policy, and legal considerations for reshoring active pharmaceutical ingredient (or “API”) and finished drug product manufacturing to the United States. The episode features Members of the Firm Delia Deschaine and Neil Di Spirito and is hosted by attorney Bonnie Scott.

Event Date: Tuesday, October 13, 2020

Speaker

Delia Deschaine
Neil Di Spirito

Company

Epstein Becker Green
Epstein Becker Green

Event Webpage (Available for subscribers only)


Category(s): Pharmaceutical

Format

Podcast

Contact Speaker / Organization (Available for subscribers only)